Publication date: Aug 28, 2024
This study aimed to tailor and pilot a health education program using the PRECEDE-PROCEED model to promote vaccination and enhance self-protective behaviors against COVID-19 in Hong Kong populations. Quasi-experimental study. Phases 1-4 of the PRECEDE-PROCEED model were used to identify the needs for COVID-19 prevention. Strategies to address predisposing, reinforcing, and enabling factors in the PRECEDE-PROCEED model were developed, and an intervention package was generated thereafter. A pre-post experimental study was conducted among 50 participants to preliminarily assess the effects of the intervention based on Phases 5 and 8 of the PRECEDE-PROCEED model. The 3-month intervention package contained 16 health education videos, 36 health tips, individual consultations, regular reminders of vaccination, incentive of anti-epidemic packages, and vaccine booking services. By the third month, 33 participants took a new dose of COVID-19 vaccine, and 5 participants withdrew. The vaccination rate for new dose achieved 73. 3% (95% CI: 58. 06-85. 40%). Compared with the Hong Kong population in the same period, our study demonstrated higher increase in vaccination rate (9. 97 vs. 1. 36 doses per 1000 person-days). The percentage of early testing in personal and family level increased to 86. 7% and 84. 4%, respectively (both p < 0. 05). For correct mask wearing and hand washing, the scores increased from a baseline score of 9. 1 +/- 1. 6 and 4. 9 +/- 1. 3 to 9. 5 +/- 1. 0 and 5. 3 +/- 1. 2, respectively (both p < 0. 05). The application of the PRECEDE-PROCEED model effectively facilitated the stepwise development, implementation, and evaluation of a health education program for improving vaccination rates and fostering self-protective behaviors against infections.
Open Access PDF
Concepts | Keywords |
---|---|
Basel | COVID-19 |
Infections | PRECEDE-PROCEED |
Pilot | self-protective behaviors |
Vaccination | vaccination |
vaccine promotion |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | Infection |
disease | IDO | intervention |
disease | MESH | COVID-19 |
drug | DRUGBANK | Coenzyme M |
disease | MESH | influenza |
drug | DRUGBANK | Pentaerythritol tetranitrate |
drug | DRUGBANK | Trestolone |
drug | DRUGBANK | Cysteamine |
disease | MESH | contraindications |
disease | MESH | marital status |
disease | MESH | lifestyle factors |
disease | MESH | chronic diseases |
disease | MESH | Etiology |
drug | DRUGBANK | Serine |
drug | DRUGBANK | Ethanol |